Skip to main content
PMC home page
Gut logoLink to Gut
. 1991 Feb;32(2):220–224. doi: 10.1136/gut.32.2.220

Screening for gastrointestinal cancer: an epidemiological review.

J Weil 1, M J Langman 1
PMCID: PMC1378813  PMID: 1864546

Full text

PDF
221

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allison J. E., Feldman R. Cost benefits of hemoccult screening for colorectal carcinoma. Dig Dis Sci. 1985 Sep;30(9):860–865. doi: 10.1007/BF01309517. [DOI] [PubMed] [Google Scholar]
  2. Baird P. J. Serological evidence for the association of papillomavirus and cervical neoplasia. Lancet. 1983 Jul 2;2(8340):17–18. doi: 10.1016/s0140-6736(83)90006-5. [DOI] [PubMed] [Google Scholar]
  3. Barry M. J., Mulley A. G., Richter J. M. Effect of workup strategy on the cost-effectiveness of fecal occult blood screening for colorectal cancer. Gastroenterology. 1987 Aug;93(2):301–310. doi: 10.1016/0016-5085(87)91019-5. [DOI] [PubMed] [Google Scholar]
  4. Blackstone M. O., Riddell R. H., Rogers B. H., Levin B. Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy. Gastroenterology. 1981 Feb;80(2):366–374. [PubMed] [Google Scholar]
  5. Collins R. H., Jr, Feldman M., Fordtran J. S. Colon cancer, dysplasia, and surveillance in patients with ulcerative colitis. A critical review. N Engl J Med. 1987 Jun 25;316(26):1654–1658. doi: 10.1056/NEJM198706253162609. [DOI] [PubMed] [Google Scholar]
  6. Eddy D. M., Nugent F. W., Eddy J. F., Coller J., Gilbertsen V., Gottlieb L. S., Rice R., Sherlock P., Winawer S. Screening for colorectal cancer in a high-risk population. Results of a mathematical model. Gastroenterology. 1987 Mar;92(3):682–692. doi: 10.1016/0016-5085(87)90018-7. [DOI] [PubMed] [Google Scholar]
  7. Farrands P. A., Blake J. R., Ansell I. D., Cotton R. E., Hardcastle J. D. Endoscopic review of patients who have had gastric surgery. Br Med J (Clin Res Ed) 1983 Mar 5;286(6367):755–758. doi: 10.1136/bmj.286.6367.755. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gilbertsen V. A., McHugh R., Schuman L., Williams S. E. The earlier detection of colorectal cancers: a preliminary report of the results of the Occult Blood Study. Cancer. 1980 Jun 1;45(11):2899–2901. doi: 10.1002/1097-0142(19800601)45:11<2899::aid-cncr2820451132>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  9. Gyde S. N., Prior P., Allan R. N., Stevens A., Jewell D. P., Truelove S. C., Lofberg R., Brostrom O., Hellers G. Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres. Gut. 1988 Feb;29(2):206–217. doi: 10.1136/gut.29.2.206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Haggitt R. C., Tryzelaar J., Ellis F. H., Colcher H. Adenocarcinoma complicating columnar epithelium-lined (Barrett's) esophagus. Am J Clin Pathol. 1978 Jul;70(1):1–5. doi: 10.1093/ajcp/70.1.1. [DOI] [PubMed] [Google Scholar]
  11. Hamilton S. R., Smith R. R. The relationship between columnar epithelial dysplasia and invasive adenocarcinoma arising in Barrett's esophagus. Am J Clin Pathol. 1987 Mar;87(3):301–312. doi: 10.1093/ajcp/87.3.301. [DOI] [PubMed] [Google Scholar]
  12. Hardcastle J. D., Armitage N. C., Chamberlain J., Amar S. S., James P. D., Balfour T. W. Fecal occult blood screening for colorectal cancer in the general population. Results of a controlled trial. Cancer. 1986 Jul 15;58(2):397–403. doi: 10.1002/1097-0142(19860715)58:2<397::aid-cncr2820580235>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  13. Hardcastle J. D., Thomas W. M., Chamberlain J., Pye G., Sheffield J., James P. D., Balfour T. W., Amar S. S., Armitage N. C., Moss S. M. Randomised, controlled trial of faecal occult blood screening for colorectal cancer. Results for first 107,349 subjects. Lancet. 1989 May 27;1(8648):1160–1164. doi: 10.1016/s0140-6736(89)92750-5. [DOI] [PubMed] [Google Scholar]
  14. Lashner B. A., Hanauer S. B., Silverstein M. D. Optimal timing of colonoscopy to screen for cancer in ulcerative colitis. Ann Intern Med. 1988 Feb;108(2):274–278. doi: 10.7326/0003-4819-108-2-274. [DOI] [PubMed] [Google Scholar]
  15. Lee R. G. Dysplasia in Barrett's esophagus. A clinicopathologic study of six patients. Am J Surg Pathol. 1985 Dec;9(12):845–852. doi: 10.1097/00000478-198512000-00001. [DOI] [PubMed] [Google Scholar]
  16. Lennard-Jones J. E., Morson B. C., Ritchie J. K., Shove D. C., Williams C. B. Cancer in colitis: assessment of the individual risk by clinical and histological criteria. Gastroenterology. 1977 Dec;73(6):1280–1289. [PubMed] [Google Scholar]
  17. Lennard-Jones J. E., Morson B. C., Ritchie J. K., Williams C. B. Cancer surveillance in ulcerative colitis. Experience over 15 years. Lancet. 1983 Jul 16;2(8342):149–152. doi: 10.1016/s0140-6736(83)90129-0. [DOI] [PubMed] [Google Scholar]
  18. Lundegårdh G., Adami H. O., Helmick C., Zack M., Meirik O. Stomach cancer after partial gastrectomy for benign ulcer disease. N Engl J Med. 1988 Jul 28;319(4):195–200. doi: 10.1056/NEJM198807283190402. [DOI] [PubMed] [Google Scholar]
  19. Mandel J. S., Bond J. H., Bradley M., Snover D. C., Church T. R., Williams S., Watt G., Schuman L. M., Ederer F., Gilbertsen V. Sensitivity, specificity, and positive predictivity of the Hemoccult test in screening for colorectal cancers. The University of Minnesota's Colon Cancer Control Study. Gastroenterology. 1989 Sep;97(3):597–600. doi: 10.1016/0016-5085(89)90629-x. [DOI] [PubMed] [Google Scholar]
  20. Morson B. C. Genesis of colorectal cancer. Clin Gastroenterol. 1976 Sep;5(3):505–525. [PubMed] [Google Scholar]
  21. Morson B. C., Pang L. S. Rectal biopsy as an aid to cancer control in ulcerative colitis. Gut. 1967 Oct;8(5):423–434. doi: 10.1136/gut.8.5.423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Naef A. P., Savary M., Ozzello L. Columnar-lined lower esophagus: an acquired lesion with malignant predisposition. Report on 140 cases of Barrett's esophagus with 12 adenocarcinomas. J Thorac Cardiovasc Surg. 1975 Nov;70(5):826–835. [PubMed] [Google Scholar]
  23. Offerhaus G. J., Tersmette A. C., Huibregtse K., van de Stadt J., Tersmette K. W., Stijnen T., Hoedemaeker P. J., Vandenbroucke J. P., Tytgat G. N. Mortality caused by stomach cancer after remote partial gastrectomy for benign conditions: 40 years of follow up of an Amsterdam cohort of 2633 postgastrectomy patients. Gut. 1988 Nov;29(11):1588–1590. doi: 10.1136/gut.29.11.1588. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Ransohoff D. F., Riddell R. H., Levin B. Ulcerative colitis and colonic cancer. Problems in assessing the diagnostic usefulness of mucosal dysplasia. Dis Colon Rectum. 1985 Jun;28(6):383–388. doi: 10.1007/BF02560215. [DOI] [PubMed] [Google Scholar]
  25. Rosenstock E., Farmer R. G., Petras R., Sivak M. V., Jr, Rankin G. B., Sullivan B. H. Surveillance for colonic carcinoma in ulcerative colitis. Gastroenterology. 1985 Dec;89(6):1342–1346. doi: 10.1016/0016-5085(85)90653-5. [DOI] [PubMed] [Google Scholar]
  26. Spechler S. J., Robbins A. H., Rubins H. B., Vincent M. E., Heeren T., Doos W. G., Colton T., Schimmel E. M. Adenocarcinoma and Barrett's esophagus. An overrated risk? Gastroenterology. 1984 Oct;87(4):927–933. [PubMed] [Google Scholar]
  27. Van der Veen A. H., Dees J., Blankensteijn J. D., Van Blankenstein M. Adenocarcinoma in Barrett's oesophagus: an overrated risk. Gut. 1989 Jan;30(1):14–18. doi: 10.1136/gut.30.1.14. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES